Rapid Acting Antidepressants

Rapid Acting Antidepressants

Duman, Ronald
Krystal, John

190,32 €(IVA inc.)

The Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series INDICE: 1. Discovery of ketamine as a rapid acting antidepressant John H. Krystal 2. Ketamine for depression: Clinical issues Sanjay Johan Mathew 3. Ketamine effects on cortical functional connectivity in depression Chadi Abdallah 4. Activity dependent synaptic effects underlying the actions of ketamine Ronald Duman 5. mGluR2/3 as novel target for rapid acting antidepressants Shigeyuki Chaki 6. Effects of ketamine on excitatory and inhibitory responses Lori McMahon 7. Role of GABA interneurons in the actions of ketamine Bernhard Lüscher 8. Synaptic plasticity mechanisms / clinical studies Joseph Moskal 9. Relapse prevention with rapid-acting antidepressants Wayne Drevets 10. Clinical scopolamine studies Maura Furey 11. Ketamine biomarkers Carlos A. Zarate Jr. 12. Role of lateral habenula in the actions of ketamine Hai-Lan Hu 13. Role of ketamine metabolites in the rapid antidepressant response Panos Zanos 14. Ketamine and PTSD Dennis S. Charney 15. Involvement of muscarinic receptor mechanisms in antidepressant drug action Jeffrey Witkin 16. Clinical overview of NMDA-R antagonists and clinical practice Samuel Wilkinson 17. Role of eEF2 kinase in the actions of ketamine Lisa Monteggia

  • ISBN: 978-0-12-820189-3
  • Editorial: Academic Press
  • Encuadernacion: Cartoné
  • Páginas: 312
  • Fecha Publicación: 01/07/2020
  • Nº Volúmenes: 1
  • Idioma: Inglés